arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Xilio Therapeutics, Inc.

XLO

$9.24 ▲ +0.23 (+2.55%) at close

27 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Xilio Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $179.3M

Dividend Yield —

Revenue Growth 131.2% ↘

Op. Margin -18.7% ↗

ROIC -3.8% ↗

FCF / Share $-0.97 ↗

Trailing P/E —

Price / Book 0.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$18.69M

↑ +131.2% —

Net Income Profit after all expenses

$-6.37M

↑ +59.8% —

Operating Margin Operating profit as % of sales

-18.7%

↑ +83.3% 2th

FCF / Share Free cash flow per share

$-0.97

↑ +55.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	131.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1540%)	331.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4046%)	693.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8573%)	742.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9181%)	243.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2937%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	85.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-222.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	73.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-858.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	71.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2139.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	63.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	65.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	25.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	22.0% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	15.3% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	22.2% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	-6.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	96.6% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	97.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	96.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	12.1% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	59.8% Excellent ↑ Excellent Improving Year-over-year change in net income	28.2% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-16.2% Weak ↓ Weak Declining Year-over-year change in net income	-13.8% Weak ↓ Weak Declining Year-over-year change in net income	22.9% Good → Good Stable Year-over-year change in net income	25.8% Excellent ↑ Excellent Improving Year-over-year change in net income	16.3% Good ↓ Good Declining Year-over-year change in net income	28.1% Excellent ↑ Excellent Improving Year-over-year change in net income	24.0% Good ↑ Good Improving Year-over-year change in net income	21.4% Good ↑ Good Improving Year-over-year change in net income	21.6% Good ↑ Good Improving Year-over-year change in net income	9.4% Fair ↑ Fair Improving Year-over-year change in net income	-6.1% Weak ↑ Weak Improving Year-over-year change in net income	-14.0% Weak ↑ Weak Improving Year-over-year change in net income	-28.1% Weak ↓ Weak Declining Year-over-year change in net income	-28.1% Weak ↑ Weak Improving Year-over-year change in net income	-28.1% Weak ↑ Weak Improving Year-over-year change in net income	5.2% Fair Fair Year-over-year change in net income	-105.3% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	55.2% Excellent Excellent Year-over-year change in free cash flow	N/M	—	43.7% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	—	55.6% Excellent Excellent Year-over-year change in free cash flow	N/M	59.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	34.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	3.9% Caution ↓ Caution Declining Year-over-year change in free cash flow	-20.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	97.3% Excellent → Excellent Stable Year-over-year change in free cash flow	97.7% Excellent Excellent Year-over-year change in free cash flow	97.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-18.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-225%)	-111.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-844%)	-86.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-677%)	-10.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-167%)	-177.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1285%)	-472.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3252%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-34.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-384%)	-75.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-728%)	75.7% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+531%)	-85.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-812%)	-196.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1733%)	-452.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3873%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-100.5% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-181.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-15.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-91.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-184.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	2.95x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.40x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-2.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-1.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.25x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.37x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-3.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	18.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-160.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-102.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-53.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	9.2% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	15.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	13.2% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	19.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	18.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-2.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-1.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-13.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-19.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-21.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-29.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-21.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-16.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-10.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-9.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-56.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-8.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-13.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	29.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+96%)	201.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1241%)	-224.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1594%)	-124.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-926%)	-74.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-596%)	-66.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-546%)	-41.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-378%)	-66.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-545%)	-47.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-420%)	-31.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-313%)	-28.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-292%)	-26.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	-21.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-16.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	-14.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-12.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-10.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	12.2% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-19%)	13.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-8%)	16.8% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+12%)	24.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+66%)	12.9% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-14%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	-282.05x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-183.13x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-122.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-163.54x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-112.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-132.38x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-144.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-202.91x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-178.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-161.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-135.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-179.74x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-132.16x Weak Weak Operating income divided by interest expense Optimal: > 5x	-163.45x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-136.04M	$-150.33M	$-137.53M	$-103.76M	$-121.55M	$-89.07M	$-55.29M	$-61.26M	$-74.95M	$-33.98M	$-44.70M	$-59.77M	$-75.38M	$-93.27M	$-120.39M	$-139.14M	$-159.41M	$-176.96M	$-198.05M	$-99.77M	$-120.30M	$-141.22M	$-19.24M	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.96	$0.77	—	$0.13	$1.17	$0.04	—	$0.04	$0.04	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.33	$-0.58	$-3.76	$-0.11	$-2.30	$-0.18	$-14.33	$-0.22	$-0.24	$-0.62	$-0.64	$-0.61	$-0.70	$-0.83	$-0.82	$-0.72	$-0.90	$-0.78	$62.66	$-21.27	$-31.48	$-23.53	$-33.40	$-24.19	—	—	—
Free Cash Flow per Share (USD)	$-0.97	$-1.40	—	$-0.12	$-2.16	$0.39	—	$-0.22	$0.35	$-0.38	—	$-0.49	$-0.61	$-0.93	—	$-0.74	$-0.64	$-0.77	—	$-27.27	$-27.94	$-32.34	—	—	—	—	—
Book Value per Share (USD)	$10.98	$12.55	$7.79	$-0.16	$1.03	$0.21	$5.38	$0.33	$0.58	$0.75	$1.33	$1.91	$2.45	$3.09	$3.85	$4.61	$5.27	$6.07	$6.78	$-178.64	$-164.72	$-139.97	$-120.72	$-102.89	—	—	—
Tangible Book Value per Share (USD)	$10.98	$12.55	$7.79	$-0.16	$1.03	$0.21	$5.38	$0.33	$0.58	$0.75	$1.33	$1.91	$2.45	$3.09	$3.85	$4.61	$5.27	$6.07	$6.78	$-178.64	$-164.72	$-139.97	$-120.72	$-102.89	—	—	—
Basic Weighted Avg Shares (shares)	19.40M	16.35M	—	144.11M	6.89M	74.70M	—	63.47M	57.76M	27.91M	—	27.52M	27.47M	27.43M	—	27.40M	27.38M	27.37M	—	763,869	736,473	708,264	—	612,657	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$111.27M	$111.25M	$88.75M	$67.69M	—	$45.56M	$32.97M	—	—	$37.60M	$32.17M	—	—	$80.78M	$103.38M	—	—	$168.86M	$189.74M	—	—	—	$-1.56M	—	—	—	—
Total Equity (USD)	$72.26M	$72.55M	$35.27M	$-8.10M	$7.07M	$10.70M	$17.60M	$20.97M	$33.42M	$25.77M	$36.83M	$52.50M	$67.38M	$84.79M	$105.65M	$126.30M	$144.22M	$166.12M	$185.43M	$-136.46M	$-121.31M	$-99.14M	$-83.29M	$-63.03M	$-48.90M	$-37.55M	$-29.52M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$18.69M	$12.65M	$13.69M	$19.07M	$8.08M	$2.93M	$1.72M	$2.26M	$2.36M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$331.00K	$344.00K	$323.00K	$340.00K	$381.00K	$497.00K	$376.00K	$380.00K	$445.00K	$443.00K	$449.00K	$460.00K	$492.00K	$499.00K	$489.00K	$473.00K	$445.00K	$440.00K	$394.00K	$382.00K	$373.00K	$350.00K	$341.00K	—	—	—	—
Net Income, GAAP (USD)	$-6.37M	$-9.53M	$10.36M	$-16.29M	$-15.84M	$-13.27M	$-13.09M	$-14.02M	$-13.93M	$-17.20M	$-17.66M	$-16.75M	$-19.36M	$-22.65M	$-22.47M	$-21.35M	$-21.35M	$-21.35M	$-19.70M	$-16.67M	$-16.67M	$-16.67M	$-20.77M	$-8.12M	—	—	—
Operating Cash Flow (USD)	$-18.76M	$-22.34M	$-2.00M	$-17.50M	$-14.48M	$28.98M	$-14.16M	$-13.67M	$19.95M	$-10.50M	$-13.43M	$-13.37M	$-16.57M	$-25.25M	$-18.22M	$-19.91M	$-16.76M	$-20.84M	$-17.16M	$-20.72M	$-20.14M	$-22.73M	$-12.71M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters

Xilio Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare XLO with peers